Celltrion Pharm Financials
| 068760 Stock | KRW 62,400 900.00 1.46% |
Celltrion |
Understanding current and past Celltrion Pharm Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Celltrion Pharm's financial statements are interrelated, with each one affecting the others. For example, an increase in Celltrion Pharm's assets may result in an increase in income on the income statement.
Please note, the presentation of Celltrion Pharm's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Celltrion Pharm's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Celltrion Pharm's management manipulating its earnings.
Celltrion Pharm Stock Summary
Celltrion Pharm competes with Medy Tox, and Soulbrain Holdings. Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju, South Korea. Celltrionph is traded on Korean Securities Dealers Automated Quotations in South Korea.| Instrument | Korea Stock View All |
| Exchange | KOSDAQ |
| ISIN | KR7068760008 |
| Business Address | 82, 2sandan-ro, Cheongju, |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.celltrionph.com |
| Phone | 82 4 3717 7000 |
| Currency | KRW - South Korean Won |
You should never invest in Celltrion Pharm without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Celltrion Stock, because this is throwing your money away. Analyzing the key information contained in Celltrion Pharm's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Celltrion Pharm Key Financial Ratios
Celltrion Pharm's financial ratios allow both analysts and investors to convert raw data from Celltrion Pharm's financial statements into concise, actionable information that can be used to evaluate the performance of Celltrion Pharm over time and compare it to other companies across industries.| Return On Equity | 0.0891 | |||
| Return On Asset | 0.0341 | |||
| Target Price | 136000.0 | |||
| Number Of Employees | 29 | |||
| Beta | 0.23 |
Celltrion Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Celltrion Pharm's current stock value. Our valuation model uses many indicators to compare Celltrion Pharm value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Celltrion Pharm competition to find correlations between indicators driving Celltrion Pharm's intrinsic value. More Info.Celltrion Pharm is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.38 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Celltrion Pharm is roughly 2.61 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Celltrion Pharm by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Celltrion Pharm's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Celltrion Pharm Systematic Risk
Celltrion Pharm's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Celltrion Pharm volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Celltrion Pharm correlated with the market. If Beta is less than 0 Celltrion Pharm generally moves in the opposite direction as compared to the market. If Celltrion Pharm Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Celltrion Pharm is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Celltrion Pharm is generally in the same direction as the market. If Beta > 1 Celltrion Pharm moves generally in the same direction as, but more than the movement of the benchmark.
Celltrion Pharm December 25, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Celltrion Pharm help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Celltrion Pharm. We use our internally-developed statistical techniques to arrive at the intrinsic value of Celltrion Pharm based on widely used predictive technical indicators. In general, we focus on analyzing Celltrion Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Celltrion Pharm's daily price indicators and compare them against related drivers.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 16.29 | |||
| Value At Risk | (5.48) | |||
| Potential Upside | 4.59 |
Complementary Tools for Celltrion Stock analysis
When running Celltrion Pharm's price analysis, check to measure Celltrion Pharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celltrion Pharm is operating at the current time. Most of Celltrion Pharm's value examination focuses on studying past and present price action to predict the probability of Celltrion Pharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celltrion Pharm's price. Additionally, you may evaluate how the addition of Celltrion Pharm to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |